CA2358395C - Formulations a liberation prolongee de derives d'erythromycine - Google Patents
Formulations a liberation prolongee de derives d'erythromycine Download PDFInfo
- Publication number
- CA2358395C CA2358395C CA002358395A CA2358395A CA2358395C CA 2358395 C CA2358395 C CA 2358395C CA 002358395 A CA002358395 A CA 002358395A CA 2358395 A CA2358395 A CA 2358395A CA 2358395 C CA2358395 C CA 2358395C
- Authority
- CA
- Canada
- Prior art keywords
- extended release
- pharmaceutical composition
- release pharmaceutical
- composition
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composition pharmaceutique à libération prolongée comprenant un dérivé de l'érythromycine et un polymère acceptable sur le plan pharmaceutique. La composition présente un profil de goût amélioré comparativement à une composition à libération immédiate de dérivé de l'érythromycine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002465698A CA2465698A1 (fr) | 1997-04-11 | 1998-03-06 | Formulations a liberation prolongee de derives d'erythromycine |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/838,900 US6010718A (en) | 1997-04-11 | 1997-04-11 | Extended release formulations of erythromycin derivatives |
US08/838,900 | 1997-04-11 | ||
CA002325541A CA2325541C (fr) | 1997-04-11 | 1998-03-06 | Formulations a liberation prolongee de derives d'erythromycine |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002325541A Division CA2325541C (fr) | 1997-04-11 | 1998-03-06 | Formulations a liberation prolongee de derives d'erythromycine |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002465698A Division CA2465698A1 (fr) | 1997-04-11 | 1998-03-06 | Formulations a liberation prolongee de derives d'erythromycine |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2358395A1 CA2358395A1 (fr) | 1998-10-22 |
CA2358395C true CA2358395C (fr) | 2004-07-27 |
Family
ID=25682218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002358395A Expired - Lifetime CA2358395C (fr) | 1997-04-11 | 1998-03-06 | Formulations a liberation prolongee de derives d'erythromycine |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2358395C (fr) |
-
1998
- 1998-03-06 CA CA002358395A patent/CA2358395C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2358395A1 (fr) | 1998-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2285266C (fr) | Formulations a liberation prolongee de derives d'erythromycine | |
US6872407B2 (en) | Extended release formulations of erythromycin derivatives | |
PL197448B1 (pl) | Preparat farmaceutyczny o zmodyfikowanym uwalnianiu zawierający amoksycylinę i klawulanian potasowy oraz zastosowanie amoksycyliny i klawulanianu potasowego | |
US20050064033A1 (en) | Extended release formulations of erythromycin derivatives | |
US20040024018A1 (en) | Sustained-release preparations of quinolone antibiotics and method for preparation thereof | |
WO2004078111A2 (fr) | Compositions de minocycline a liberation prolongee et leurs procedes de preparation | |
CA2358395C (fr) | Formulations a liberation prolongee de derives d'erythromycine | |
CA2325541C (fr) | Formulations a liberation prolongee de derives d'erythromycine | |
AU2007201031B2 (en) | Extended release formulations of erythromycin derivatives | |
AU773863B2 (en) | Extended release formulations of erythromycin derivatives | |
AU2003270948B2 (en) | Extended Release Formulations of Erythromycin Derivatives | |
CA2465698A1 (fr) | Formulations a liberation prolongee de derives d'erythromycine | |
AU2006201001A1 (en) | Extended release formulations of erythromycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20180306 |
|
MKEX | Expiry |
Effective date: 20180306 |